Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc.
Industry · 15 registered clinical trials.
Status
Trial
Phase
Started
Suspended
A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate C
Prostatic Neoplasm
Phase 1
2011-03-01
Terminated
Study of EZN-2208 Pediatric Patients With Solid Tumors
Solid Tumors
Phase 1 / Phase 2
2010-02-01
Terminated
A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer
Metastatic Breast Cancer
Phase 2
2009-11-01
Unknown
A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma
Metastatic Colorectal Cancer
Phase 2
2009-06-01
Withdrawn
A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropen
Cancer, Hematologic Diseases, Fever
Phase 1
2007-06-01
Completed
A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Sol
Lymphoma, Advanced Solid Tumors
Phase 1
2007-05-01
Completed
A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Sol
Advanced Solid Tumors, Lymphoma
Phase 1
2007-05-01
Completed
Phase 1 Study of EZN-2968 Weekly in Adult Patients With Advanced Solid Tumors or Lymphoma
Carcinoma, Lymphoma
Phase 1
2007-03-01
Terminated
A Multicenter Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients
Liver Transplantation
Phase 1
2006-12-01
Withdrawn
Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Ne
Fever, Sweats, and Hot Flashes, Infection, Leukemia
Phase 1
2006-11-01
Completed
Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant
Multiple Myeloma
Phase 1
2006-09-01
Terminated
A Study Evaluating IV Oncaspar® and IV Gemzar® in the Treatment of Solid Tumors and Lymphoma
Tumors, Lymphoma
Phase 1
2006-07-01
Terminated
Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophagea
Cancer of Stomach, Gastroesophageal Cancer
Phase 2
2003-12-01
Suspended
Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma
Sarcoma, Soft Tissue
Phase 2
2003-08-01
Terminated
Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas
Neoplasm, Lymphomas, Neoplasm Metastasis
Phase 1
2001-05-01